86 related articles for article (PubMed ID: 16909047)
1. Tissue plasminogen activator-induced ischemic injury is reversed by NMDA antagonist MK-801 in vivo.
Kilic E; Kilic U; Bahr M; Hermann DM
Neurodegener Dis; 2005; 2(2):49-55. PubMed ID: 16909047
[TBL] [Abstract][Full Text] [Related]
2. Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.
Kilic E; Kilic U; Reiter RJ; Bassetti CL; Hermann DM
J Pineal Res; 2005 Sep; 39(2):151-5. PubMed ID: 16098092
[TBL] [Abstract][Full Text] [Related]
3. Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo.
Crome O; Doeppner TR; Schwarting S; Müller B; Bähr M; Weise J
J Neurosci Res; 2007 Jun; 85(8):1734-43. PubMed ID: 17455321
[TBL] [Abstract][Full Text] [Related]
4. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats.
Calcina F; Barocelli E; Bertoni S; Furukawa O; Kaunitz J; Impicciatore M; Sternini C
Neuroscience; 2005; 134(1):39-49. PubMed ID: 15939544
[TBL] [Abstract][Full Text] [Related]
6. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
[TBL] [Abstract][Full Text] [Related]
7. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia.
Zhou C; Li C; Yu HM; Zhang F; Han D; Zhang GY
J Neurosci Res; 2008 Oct; 86(13):2973-83. PubMed ID: 18512761
[TBL] [Abstract][Full Text] [Related]
10. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
Tanaka Y; Marumo T; Omura T; Yoshida S
Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
[TBL] [Abstract][Full Text] [Related]
11. Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice.
Zechariah A; ElAli A; Hermann DM
Stroke; 2010 May; 41(5):1008-12. PubMed ID: 20360548
[TBL] [Abstract][Full Text] [Related]
12. Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats.
Wang L; Kittaka M; Sun N; Schreiber SS; Zlokovic BV
J Cereb Blood Flow Metab; 1997 Feb; 17(2):136-46. PubMed ID: 9040492
[TBL] [Abstract][Full Text] [Related]
13. A new rat model of thrombotic focal cerebral ischemia.
Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
[TBL] [Abstract][Full Text] [Related]
14. [NMDA receptor antagonists in focal cerebral ischemia. An experimental model].
Nathal E; Miquelajauregui JM; Herreman F; Alvarado R; Romero V; Mateos Gomez JH
Gac Med Mex; 1993; 129(2):125-30. PubMed ID: 7926393
[TBL] [Abstract][Full Text] [Related]
15. Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation.
Hennebert O; Laudenbach V; Laquerriere A; Verney C; Carmeliet P; Marret S; Leroux P
Neuroscience; 2005; 130(3):697-712. PubMed ID: 15590153
[TBL] [Abstract][Full Text] [Related]
16. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
17. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning.
Cho S; Park EM; Zhou P; Frys K; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 2005 Apr; 25(4):493-501. PubMed ID: 15689953
[TBL] [Abstract][Full Text] [Related]
18. Temporal patterns of motor behavioural improvements by MK-801 in Mongolian gerbils submitted to different duration of global cerebral ischemia.
Janać B; Selaković V; Radenović L
Behav Brain Res; 2008 Dec; 194(1):72-8. PubMed ID: 18655805
[TBL] [Abstract][Full Text] [Related]
19. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
20. Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats.
Liang W; Chuan-Zhen L; Qiang D; Jian Q; Hui-Min R; Bao-Guo X
Brain Res; 2004 Jul; 1015(1-2):175-80. PubMed ID: 15223382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
